Gen-Probe Aptima Assay for Chlamydia Trachomatis
Dna Probe, Nucleic Acid Amplification, Chlamydia. 510(k) K043072, from Gen-Probe, Inc. (San Diego, CA). Product code MKZ, class 1.
As of Nov 22, 2026, K043072 is an FDA 510(k) held by Gen-Probe, Inc., substantially equivalent on Jan 27, 2005 after 80 days, with no recalls tied to it in FDA's recall database.
- Review time: 80 days
- Recalls: 0
- Cited as a predicate by: 1 device
The APTIMA Assay for Chlamydia trachomatis is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) in clinician-collected endocervical, vaginal and male urethral swab specimens, patient-collected vaginal swab specimens*, and female and male urine specimens.
- Aptima® Chlamydia trachomatis AssayK230451 · Hologic, Inc. · Nov 16, 2023
- Aptima® Chlamydia trachomatis AssayK230451 · Hologic, Inc. · Nov 16, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 8, 2004
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3120
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files